Table 1 Clinical and biochemical data of the studied groups

Age

9.14 ± 7.59

10.62 ± 3.49

10.7 ± 4.51

Gender (M/F)

15 (46.88%) /17(53.12%)

25(54.35%) /21(45.65%)

40(57.14%) /30(42.86%)

BMI(kg/m²)

17.64 ± 1.17

18.89 ± 3.00

20.88 ± 1.50

SBP (mmHg)

98.66 ± 6.66

127.13 ± 18.37 ^b*

94.55 ± 9.80

DBP (mmHg)

64.66 ± 6.67

85.15 ± 13.76 ^b*

60.59 ± 10.11

Creatinine (mg/dl)

3.93 ± 3.75 ^a*

6.32 ± 1.55 ^b*

0.77 ± 0.34

Predialysis urea, (mg/dl)

51.12 ± 10.45 ^a*

71.56 ± 20.61 ^b*

7.80 ± 2.64

eGFR, ml_min_1 _1.73m2

15.41 ± 1.76 ^a**

11.30 ± 3.35 ^b**

87 ± 8.9

Dialysis, Yrs

2.75 ± 1.59

Nephropathies:

0

17

14

2

8

6

4

2

0

2

4

17

2

0

Antihypertensive drugs:

2

2

0

9

6

17

10

29

Kt/V

1.69 ± 0.42

Total cholesterol (mg/dl)

164.44 ± 50.10

193.04 ± 51.37 ^b*

160.31 ± 18.74

Triglycerides (mg/dl)

160.78 ± 57.33 ^a**

147.00 ± 66.98 ^b**

65.31 ± 18.35

HDL cholesterol (mg/dl)

21.35 ± 1.17^a*

27.34 ± 9.88 ^b*

39.55 ± 7.94

hs-CRP, mg/dl

3.04 ± 3.24

3.62 ± 3.97 ^b*

1.36 ± 0.67

IL6(pg/ml)

59.50 ± 46.48 ^a*

19.10 ± 23.68 ^b**

3.17 ± 1.56

Adiponectin (μg/ml)

154.00 ± 7.18 ^a**

52.44 ± 19.1 ^b**

24.80 ± 8.23